
INOVIO Reports First Quarter Financials, Prepares for Major Drug Submissions
PLYMOUTH MEETING, PA — INOVIO Pharmaceuticals (NASDAQ: INO) has released its financial results for the first quarter of 2024, revealing significant developments in its drug pipeline and a strengthened balance …
INOVIO Reports First Quarter Financials, Prepares for Major Drug Submissions Read More